New school safety guidelines from CDC... Mar 20
FUJIFILM Diosynth Biotechnologies announced that production has begun in Texas on two different COVID-19 vaccine candidates with support from the U.S. government... Jan 19
The new agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, bringing the total potential U.S. supply to over ... Jan 13
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its VITROS® SARS-CoV-2 Antigen Test, designed to detect active infection, ... Jan 13
Opaganib potentially minimizes likelihood of resistance due to viral mutations by targeting a human cell component involved in viral replication ... Dec 22
The results also show that opaganib inhibits SARS-CoV-2 virus replication and proinflammatory markers in relevant preclinical models ... Dec 17
This agreement will support the ongoing efforts by the Ministry to secure early access to a COVID-19 vaccine for the people of Israel... Dec 05
The independent, pre-programmed DSMB unanimously recommends the continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia... Nov 23
The clinical evidence from Regeneron's outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis ... Nov 23
The European Commission has granted marketing authorization for Supemtek®, a quadrivalent (four-strain) recombinant influenza vaccine, for the prevention of influenza in adults aged 18 ... Nov 20
This agreement comes as the UK continues its efforts to secure access to safe and effective COVID-19 vaccines... Nov 19
First FDA approved antibody treatment for Ebola... Oct 19
The goal of AstraZeneca's partnership with the U.S. Government is to develop a monoclonal antibody cocktail that can help prevent infection.... Oct 10
The combination of two LAABs is also designed to reduce the risk of resistance developed by the SARS-CoV-2 virus.... Oct 09
... Oct 07
Regenerons REGN-COV2 antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients... Oct 02
Veeva Vault CDMS and Bioforum selected to optimize clinical data management for RedHill’s global Phase 2/3 clinical trial ... Sep 25
CHMP has adopted a positive opinion for Supemtek for active immunization for the prevention of influenza in adults... Sep 23
The Company is committed to bringing an affordable vaccine to the public on a not-for-profit basis for emergency pandemic use... Sep 23
Oral Covid vaccine gains ground... Sep 18
In her first annual State of the European Union address, Ursula von der Leyen said the coronavirus pandemic ... Sep 17
AstraZeneca closer to COVID vaccine as 3rd phase trial starts... Sep 01
FUJIFILM Diosynth Biotechnologies will support COVID-19 vaccine candidate manufacturing, as part of Operation Warp Speed, a U.S. government program... Jul 31
... Jul 17
-Advertisements-
.jpeg)
Friday, April 04, 2025
.jpeg)
.jpeg)
.jpeg)
.jpeg)
